METASTATIS--BIOLOGICAL PHENOTYPE AND MODELS FOR THERAPY
METASTATIS--BIOLOGICAL PHENOTYPE AND MODELS FOR THERAPY
批准号:
3190675
负责人:
DOROTHEE M HERLYN
金额:
$19.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-06-21 至 1995-05-31
关键词:
aminopeptidase antisense nucleic acid athymic mouse basement membrane bladder neoplasm carcinoma cell adhesion molecules cell motility cell population study cellular oncology circulating neoplastic cell clone cells colorectal neoplasms extracellular matrix extracellular matrix proteins fibronectins host neoplasm interaction human tissue immunoelectron microscopy in situ hybridization melanoma messenger RNA metastasis monoclonal antibody neoplasm /cancer invasiveness neoplasm /cancer therapy neoplasm /cancer transplantation neoplastic cell skin transplantation transfection tumor antigens
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Human skin reconstructs in vitro and human skin grafts on athymic nude or
SCID mice represent new tools for studying invasion and metastasis because
they mimic the complex interactions of human melanoma cells with
surrounding normal cells. These newly developed orthotopic models will be
characterized for the expression of mRNA and antigens using in situ
hybridization and antibody binding techniques. Invasion and metastasis
models, will also be used to delineate the functional roles during invasion
and metastasis of two tumor cell surface structures and one tumor-derived
extracellular matrix protein. Each of these cellular components was chosen
based on its selective expression on malignant cells from invasive lesions.
The role for vitronectin receptor in melanoma invasion and metastasis will
be investigated by selecting with monoclonal antibodies variant cells that
do not express either the beta3 or the alphav subunits. Alternatively,
antisense RNA constructs will be transfected into metastatic cells. The
function of the cell surface metalloproteinase aminopeptidase N in invasion
and metastasis will be determined using monoclonal antibodies and a
specific inhibitor and the hypothesis will be tested that aminopeptidase N
is involved either in the activation of matrix-degrading collagenases or in
disrupting cell-cell adhesion. To investigate the role of the
extracellular matrix protein tenascin in invasion and metastasis,
monoclonal antibodies to five distinct determinants will be used to
delineate with ultrastructural and biochemical techniques those epitopes on
the tenascin molecule that are involved in tumor cell motility. The
systematic investigations of tumor-derived components related to invasion
and metastasis will help to understand the mechanisms of metastasis and to
develop novel strategies for therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Breaking tolerance to mEGP self-antigen
-
批准号:7164454
-
项目类别:
-
资助金额:$22.25万
-
财政年份:2006
-
负责人:DOROTHEE M HERLYN
-
依托单位:
Breaking tolerance to mEGP self-antigen
-
批准号:7536069
-
项目类别:
-
资助金额:$23.92万
-
财政年份:2006
-
负责人:DOROTHEE M HERLYN
-
依托单位:
Breaking tolerance to mEGP self-antigen
-
批准号:7030572
-
项目类别:
-
资助金额:$22.62万
-
财政年份:2006
-
负责人:DOROTHEE M HERLYN
-
依托单位:
Breaking tolerance to mEGP self-antigen
-
批准号:7323314
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2006
-
负责人:DOROTHEE M HERLYN
-
依托单位:
CTL-based Immunotherapy in an Organotypic Me
-
批准号:6990749
-
项目类别:
-
资助金额:$15.91万
-
财政年份:2004
-
负责人:DOROTHEE M HERLYN
-
依托单位:
EGF-RvIII in Breast Cancer
-
批准号:6611550
-
项目类别:
-
资助金额:$25.3万
-
财政年份:2003
-
负责人:DOROTHEE M HERLYN
-
依托单位:
EGF-RvIII in Breast Cancer
-
批准号:6735640
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2003
-
负责人:DOROTHEE M HERLYN
-
依托单位:
EGF-RvIII in Breast Cancer
-
批准号:6868153
-
项目类别:
-
资助金额:$25.91万
-
财政年份:2003
-
负责人:DOROTHEE M HERLYN
-
依托单位:
PATIENTS' IMMUNE RESPONSES
-
批准号:6563877
-
项目类别:
-
资助金额:$22.84万
-
财政年份:2002
-
负责人:DOROTHEE M HERLYN
-
依托单位:
CORE--IMMUNOLOGY
-
批准号:6563878
-
项目类别:
-
资助金额:$22.84万
-
财政年份:2002
-
负责人:DOROTHEE M HERLYN
-
依托单位:
Melanoma antigens recognized by B and T helper lymphocytes
-
批准号:6594573
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2002
-
负责人:DOROTHEE M HERLYN
-
依托单位:
Melanoma antigens recognized by B and T helper lymphocytes
-
批准号:6659180
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2002
-
负责人:DOROTHEE M HERLYN
-
依托单位:
CORE--IMMUNOLOGY
-
批准号:6410218
-
项目类别:
-
资助金额:$22.84万
-
财政年份:2001
-
负责人:DOROTHEE M HERLYN
-
依托单位:
Melanoma antigens recognized by B and T helper lymphocytes
-
批准号:6459000
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2001
-
负责人:DOROTHEE M HERLYN
-
依托单位:
PATIENTS' IMMUNE RESPONSES
-
批准号:6410217
-
项目类别:
-
资助金额:$22.84万
-
财政年份:2001
-
负责人:DOROTHEE M HERLYN
-
依托单位:
PATIENTS' IMMUNE RESPONSES
-
批准号:6300548
-
项目类别:
-
资助金额:$15.41万
-
财政年份:2000
-
负责人:DOROTHEE M HERLYN
-
依托单位:
CORE--IMMUNOLOGY
-
批准号:6300549
-
项目类别:
-
资助金额:$15.41万
-
财政年份:2000
-
负责人:DOROTHEE M HERLYN
-
依托单位:
MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS
-
批准号:6443294
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2000
-
负责人:DOROTHEE M HERLYN
-
依托单位:
MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS
-
批准号:6197756
-
项目类别:
-
资助金额:$14.02万
-
财政年份:2000
-
负责人:DOROTHEE M HERLYN
-
依托单位:
Melanoma antigens recognized by B and T helper lymphocytes
-
批准号:6300192
-
项目类别:
-
资助金额:$13.09万
-
财政年份:2000
-
负责人:DOROTHEE M HERLYN
-
依托单位:
海外基金